SCHEMBL21538029

SCHEMBL21538029

CC(C)C(=O)COCC=O

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16276160 0.80 FAAH (0.39) —
SCHEMBL10060469 0.80 ALDH1A1 (0.30) TDP1
SCHEMBL13542695 0.75 MEN1 (0.37) TDP1
SCHEMBL7195371 0.74 TDP1 (0.40) TDP1
SCHEMBL23696048 0.73 MEN1 (0.40) TDP1
SCHEMBL12600744 0.73 — —
SCHEMBL22856475 0.73 MEN1 (0.40) TDP1
SCHEMBL10165857 0.73 — —
SCHEMBL23696339 0.73 MEN1 (0.40) TDP1
SCHEMBL21564105 0.71 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10464941-B2 Therapeutic compounds REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 2019-11-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10464941-B2 Therapeutic compounds SDHA, CYP11B2, SDHB TDP1 2697/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback